Nitrofurantoin: new advice on use in renal impairment

Nitrofurantoin can now be used in patients with moderate renal impairment.

Prescribers should consider checking renal function when choosing to treat with nitrofurantoin, especially in the elderly.
Prescribers should consider checking renal function when choosing to treat with nitrofurantoin, especially in the elderly.

Until recently, use of nitrofurantoin was contraindicated in patients with an estimated glomerular filtration rate (eGFR) less than 60ml/min/1.73m2. However, the latest advice from the MHRA states that the drug can now be used in patients with an eGFR greater than 45ml/min/1.73m2.

Following a review of the evidence, the MHRA concluded that, in the context of increasing resistance of lower urinary tract pathogens to standard therapy and the risk of Clostridium difficile colitis associated with widespread use of alternative broad-spectrum antibiotics, the eGFR cut-off of 60ml/min/1.73m2 was no longer supported.

In certain instances nitrofurantoin may also be prescribed for patients with an eGFR of 30 to 44ml/min/1.73m2. Use in such patients should be limited to a short course of 3—7 days for the treatment of lower UTI with suspected or proven multidrug-resistant pathogens where the benefits of nitrofurantoin are considered to outweigh the risk of adverse effects.

Further information: MHRA Drug Safety Update, September 2014

Follow MIMS on Twitter

Sign up for MIMS bulletins

Want news like this straight to your inbox?
Sign up for our bulletins

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register
Already registered?
Sign in

More from MIMS

Vitamin D3 Supplements

Formulations and indications of colecalciferol preparations.

Avoid gout drug in patients with major cardiovascular conditions, says MHRA

Avoid gout drug in patients with major cardiovascular conditions, says MHRA

Treatment with febuxostat (Adenuric) should be avoided...

Drug shortages - live tracker

Drug shortages - live tracker

Added: Colestid Orange. Use our constantly updated...

Updated bowel disease treatment summaries published by MIMS

Updated bowel disease treatment summaries published by MIMS

Updated quick-reference summaries of the latest NICE...